back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-11-18 16:58 Tx date 2025-11-14 |
$AGN
Algernon Health Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
+178,572 vol |
748,006 | |
| Filed 2025-11-18 16:52 Tx date 2025-11-14 |
$AGN
Algernon Health Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$25,000
+357,144 vol $0.07 each |
1,502,146 | |
| Filed 2025-08-05 16:22 Tx date 2025-07-24 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 7360232 MANITOBA LTD (Indirect Ownership)
|
Subscription Rights
16 - Acquisition or disposition under a prospectus exemption
|
$60,000
+100,000 vol $0.60 each |
100,000 | |
| Filed 2025-08-05 16:16 Tx date 2018-03-01 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 7360232 MANITOBA LTD (Indirect Ownership)
|
Subscription Rights
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-03-28 22:07 Tx date 2025-03-27 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$450.00
+5,000 vol $0.09 each |
1,145,002 | |
| Filed 2025-03-28 22:07 Tx date 2025-03-26 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$150.00
+2,000 vol $0.075 each |
1,140,002 | |
| Filed 2025-03-25 22:54 Tx date 2025-03-25 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 7360232 MANITOBA LTD (Indirect Ownership)
|
Common Shares
47 - Acquisition or disposition by gift
|
-500,000 vol |
623,000 | |
| Filed 2025-03-25 22:36 Tx date 2025-03-20 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 7360232 MANITOBA LTD (Indirect Ownership)
|
Common Shares
57 - Exercise of rights
|
+700,000 vol |
1,123,000 | |
| Filed 2025-01-19 20:50 Tx date 2025-01-09 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$425.00
+5,000 vol $0.085 each |
1,138,002 | |
| Filed 2024-11-16 09:57 Tx date 2024-11-15 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,200
+15,000 vol $0.08 each |
1,133,002 | |
| Filed 2024-10-10 08:22 Tx date 2024-10-07 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$800.00
+10,000 vol $0.08 each |
1,118,002 | |
| Filed 2024-08-02 16:29 Tx date 2024-08-01 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 7360232 MANITOBA LTD (Indirect Ownership)
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$50,760
+423,000 vol $0.12 each |
423,000 | |
| Filed 2024-08-02 16:25 Tx date 2018-03-01 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 7360232 MANITOBA LTD (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-08-02 16:22 Tx date 2024-08-01 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 7360232 MANITOBA LTD (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$50,760
+423,000 vol $0.12 each |
423,000 | |
| Filed 2024-08-02 16:19 Tx date 2018-03-01 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: 7360232 MANITOBA LTD (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-06-27 17:34 Tx date 2024-06-27 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,145
+19,500 vol $0.11 each |
1,108,002 | |
| Filed 2024-06-20 16:27 Tx date 2024-06-20 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$540.00
+4,500 vol $0.12 each |
1,088,502 | |
| Filed 2024-06-06 12:04 Tx date 2024-06-05 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$350.00
+2,500 vol $0.14 each |
1,084,002 | |
| Filed 2024-06-06 12:04 Tx date 2024-06-04 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,680
+12,000 vol $0.14 each |
1,081,502 | |
| Filed 2024-05-17 14:32 Tx date 2024-05-17 |
$AGN
Algernon Pharmaceuticals Inc. |
Moreau, Christopher
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,914
+27,000 vol $0.145 each |
1,069,502 |